Back to Search
HANNAH LANE, MD
MD
Obstetrics & Gynecology Physician
NPI: 1992508303Individual
Specialties, Licenses & Credentials
Obstetrics & Gynecology PhysicianPrimary
Obstetrics & Gynecology
Code: 207V00000X
125.085738(IL)
Student in an Organized Health Care Education/Training Program
Student in an Organized Health Care Education/Training Program
Code: 390200000X
Research & Publications (20)
Optimal targeting of the mTORC1 kinase in human cancer.
PMID 19233631·Curr Opin Cell Biol·2009
6-review
Prefrontal executive function and D1, D3, 5-HT2A and 5-HT6 receptor gene variations in healthy adults.
PMID 18197272·J Psychiatry Neurosci·2008
8-other
Prophylactic use of mitomycin-C in the management of a buttonholed LASIK flap.
PMID 12648655·J Cataract Refract Surg·2003
5-case
Identification of euglenophycin--a toxin found in certain euglenoids.
PMID 19615398·Toxicon·2010
7-preclinical
Can specific pain symptoms help in the diagnosis of endometriosis? A cohort study of women with chronic pelvic pain.
PMID 19342028·Fertil Steril·2010
4-observational
Phase II randomized study of neoadjuvant everolimus plus letrozole compared with placebo plus letrozole in patients with estrogen receptor-positive breast cancer.
PMID 19380449·J Clin Oncol·2009
3-trial
Interleukin-2 cycling causes transient increases in high-sensitivity C-reactive protein and D-dimer that are not associated with plasma HIV-RNA levels.
PMID 19617815·AIDS·2009
2-rct
AKT/mTOR pathway activation and BCL-2 family proteins modulate the sensitivity of human small cell lung cancer cells to RAD001.
PMID 19228731·Clin Cancer Res·2009
7-preclinical
Inferiority of IL-2 alone versus IL-2 with HAART in maintaining CD4 T cell counts during HAART interruption: a randomized controlled trial.
PMID 19098490·AIDS·2009
3-trial
Increased AKT S473 phosphorylation after mTORC1 inhibition is rictor dependent and does not predict tumor cell response to PI3K/mTOR inhibition.
PMID 19372546·Mol Cancer Ther·2009
8-other
Equivalent benefit of mTORC1 blockade and combined PI3K-mTOR blockade in a mouse model of tuberous sclerosis.
PMID 19527517·Mol Cancer·2009
7-preclinical
mTOR inhibitor RAD001 (everolimus) has antiangiogenic/vascular properties distinct from a VEGFR tyrosine kinase inhibitor.
PMID 19223496·Clin Cancer Res·2009
4-observational
Inhibition of ErbB2 by receptor tyrosine kinase inhibitors causes myofibrillar structural damage without cell death in adult rat cardiomyocytes.
PMID 19331811·Exp Cell Res·2009
7-preclinical
Noninvasive in vivo imaging of CD4 cells in simian-human immunodeficiency virus (SHIV)-infected nonhuman primates.
PMID 19417212·Blood·2009
7-preclinical
Serotonin-Norepinephrine Reuptake Inhibitor (SNRI) treatment for Isaacs syndrome with depression.
PMID 19328218·Prog Neuropsychopharmacol Biol Psychiatry·2009
5-case
Roles of state and trait anxiety in physical activity participation for adults with anxiety disorders.
PMID 19515629·J Formos Med Assoc·2009
8-other
Identification and characterization of CRF02_AG, CRF06_cpx, and CRF09_cpx recombinant subtypes in Mali, West Africa.
PMID 19182920·AIDS Res Hum Retroviruses·2009
8-other
Reply to comments on "Optimizing early prediction for antipsychotic response in schizophrenia".
PMID 19593183·J Clin Psychopharmacol·2009
8-other
Lack of association between AKT1 variances versus clinical manifestations and social function in patients with schizophrenia.
PMID 18635704·J Psychopharmacol·2009
4-observational
Safety and immunogenicity of multiple and higher doses of an inactivated influenza A/H5N1 vaccine.
PMID 19569973·J Infect Dis·2009
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 1875 DEMPSTER ST STE 465
PARK RIDGE, IL 60068 - Phone
- (847) 825-1100
Quick Facts
- NPI
- 1992508303
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 2
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile